Back
Verrica Pharmaceuticals Vs. Harrow Industry Stock Comparison
Sell
28
VRCA
Verrica Pharmaceuticals
Last Price:
0.87
Seasonality Move:
34.27%
Buy
54
HROW
Harrow
Last Price:
42.86
Seasonality Move:
5.55%
Sell
28
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
- The current Verrica Pharmaceuticals [VRCA] share price is $0.86. The Score for VRCA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- VRCA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Harrow (HROW)
is a Buy
Is Harrow a Buy, Sell or Hold?
- The current Harrow [HROW] share price is $42.86. The Score for HROW is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- HROW is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $0.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing slight selling pressure.
HROW Stock Price Chart
VRCA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 35.14 | Sell |
| Chaikin Money Flow: | -206201 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.96 - 1.6) | Sell |
| Bollinger Bands (100): | (0.97 - 6.19) | Sell |
HROW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 38.25 | Sell |
| Chaikin Money Flow: | 141858 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.22 - 54.28) | Sell |
| Bollinger Bands (100): | (27.28 - 49.68) | Buy |
VRCA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.83 | Buy |
| 20-day SMA: | 1.26 | Sell |
| 50-day SMA: | 1.48 | Sell |
| 200-day SMA: | 5.15 | Sell |
| 8-day EMA: | 0.94 | Sell |
| 20-day EMA: | 1.16 | Sell |
| 50-day EMA: | 1.82 | Sell |
| 200-day EMA: | 4.17 | Sell |
HROW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.13 | Sell |
| 20-day SMA: | 49.83 | Sell |
| 50-day SMA: | 47.57 | Sell |
| 200-day SMA: | 25.76 | Buy |
| 8-day EMA: | 48.52 | Sell |
| 20-day EMA: | 48.9 | Sell |
| 50-day EMA: | 46.29 | Sell |
| 200-day EMA: | 31.19 | Buy |
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.73 per share.
Harrow Earnings Growth & HROW Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and an increase next year of $1.01 per share.
Verrica Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Harrow Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||